Diabetes News and Research

Latest Diabetes News and Research

Overweight children more likely to take prescription medications

Overweight children are far more likely to take prescription medications than children of a normal weight-a trend that adds to already higher health-care costs for treating childhood obesity, according to new research from the University of Alberta.

5 Oct 2012

Myocardial infarction mortality rates decrease by 44% over the last 15 years in Argentina

Mortality caused by myocardial infarction has decreased by 44% over the last 15 years in Argentina, according to new research which will be presented during the 38th Argentine Congress of Cardiology.

5 Oct 2012

Diabecline wins Drug Store News Best New Product award

Diabecline first aid antibiotic, offered by pharmaCline, has been named the winner of the Drug Store News Best New Product award.

5 Oct 2012

Urinary adiponectin as a marker for diabetic nephropathy

Urinary adiponectin may provide a novel biomarker for diabetic nephropathy, shows research from Finland.

4 Oct 2012

Selective screening misses gestational diabetes

Selective screening for gestational diabetes does not always identify women who have the condition, shows research.

4 Oct 2012

InsuPad device may improve insulin therapy

A novel device is currently under development for aiding insulin analog therapy in diabetes patients, report researchers.

4 Oct 2012

Diclofenac increases risk for anastomotic leakage after colorectal surgery

The use of cyclo-oxygenase-2 nonsteroidal anti-inflammatory drugs increases the risk for anastomotic leakage after colorectal surgery, research shows.

4 Oct 2012

Age impacts salivary markers of oxidative stress, oral pathology

Age has a significant impact on the variance of salivary markers of oxidative stress, and could shed light on the pathogenesis of oral diseases, report Slovakian researchers.

4 Oct 2012

Beta blockers do not lower cardiac risk in patients with or without CAD

Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.

4 Oct 2012

Chronic kidney disease independently increases mortality risk

Findings from two meta-analyses published in The Lancet show that patients with chronic kidney disease are at high risk for death and end-stage renal disease even if they do not have comorbid hypertension or diabetes.

4 Oct 2012

Insulin degludec shows promise in diabetes

Self-administration of daily insulin degludag injections is no less effective than self-injecting insulin glargine in patients with diabetes who are new to insulin therapy, say researchers.

4 Oct 2012

Antibiotic proved to be Achilles’ heel for some

US clinicians have identified patients at particular risk for Achilles injury while using quinolones.

4 Oct 2012

Heart attacks linked with mortality risk in people with schizophrenia

The risk of death resulting from heart attack is higher in people with schizophrenia than in the general public, according to scientists at the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES).

4 Oct 2012

Scripps Health receives Qualcomm Foundation grant to support digital medicine research projects

Scripps Health announced today that it has been awarded a $3.75 million grant from the Qualcomm Foundation, to be used for the Scripps Translational Science Institute, which was established by Scripps Health in collaboration with various parties to support the development of breakthrough digital technologies designed to revolutionize the practice of medicine.

4 Oct 2012

Long-term survivors of hematopoietic cell transplants more likely to develop heart disease

New research appearing online today in Blood, the Journal of the American Society of Hematology (ASH), suggests that long-term survivors of hematopoietic cell transplants (HCT) are at an increased risk of developing heart disease risk factors such as high blood pressure, diabetes, and high cholesterol when compared to the general population.

4 Oct 2012

Beta-blockers not associated with reduced risk of heart attacks, death and strokes

A new study conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found using beta-blockers, the standard of care for patients with coronary artery disease (CAD), was not associated with a lower risk of heart attacks, death and strokes in patients suffering from CAD and those with risk factors for the disease, including those with a history of heart attack.

4 Oct 2012

Gender-specific group therapy effective in treating depressed women with Type 2 diabetes

Gender-specific group therapy is effective for treating depressed women with Type 2 diabetes, according to a study published in the latest issue of the Annals of Behavioral Medicine and funded by the National Institute of Nursing Research.

4 Oct 2012

Bristol-Myers Squibb, Sanofi restructure long-term alliance

Sanofi and Bristol-Myers Squibb Company today announced they have restructured their successful long-term alliance following the loss of exclusivity of Plavix and Avapro/Avalide in many major markets.

4 Oct 2012

The Center Helping Obesity In Children End Successfully receives Aetna Foundation grant

The Aetna Foundation, the philanthropic arm of Aetna, has awarded a $40,000 grant to The Center Helping Obesity In Children End Successfully (C.H.O.I.C.E.S.), an Atlanta-based nonprofit organization that works with communities in the metropolitan area to fight childhood obesity.

4 Oct 2012

FDA grants Fast Track designation to XBiotech’s Xilonix for treatment of cachexia

XBiotech, a privately held biotechnology company, announced today that the company has been granted Fast Track designation for its anti-cachexia drug Xilonix.

4 Oct 2012